<p>美国银行证券分析师在 5 月 6 日维持了对 Laekna, Inc.的买入评级，并设定了 23.50 港元的目标价。该公司的股票上周三收于 13.31 港元。</p>
<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
<p>目前，分析师对 Laekna, Inc.的共识评级为强烈买入，平均目标价为 28.62 港元。</p>

来凯医药-B

<p>美国银行证券分析师在 5 月 6 日维持了对 Laekna, Inc.的买入评级，并设定了 23.50 港元的目标价。该公司的股票上周三收于 13.31 港元。Claim 55% Off TipRanks 解锁对冲基金级别的数据和强大的投资工具，以便做出更聪明、更精准的决策。发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用 Smart Investor Picks。目前，分析师对 Laekna, Inc.的共识评级为强烈买入，平均目标价为 28.62 港元</p>

<p>Bank of America Securities analyst maintained a Buy rating on Laekna, Inc. on May 6 and set a price target of HK$23.50. The company’s shares closed last Wednesday at HK$13.31.</p>
<div class="lb-trans"><p>美国银行证券分析师在 5 月 6 日维持了对 Laekna, Inc.的买入评级，并设定了 23.50 港元的目标价。该公司的股票上周三收于 13.31 港元。</p>
</div><h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
</div><p>Currently, the analyst consensus on Laekna, Inc. is a Strong Buy with an average price target of HK$28.62.</p>
<div class="lb-trans"><p>目前，分析师对 Laekna, Inc.的共识评级为强烈买入，平均目标价为 28.62 港元。</p>
</div>

Bank of America Securities Reaffirms Their Buy Rating on Laekna, Inc. (2105)

Tip Ranks

美国银行

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

美国银行证券重申对来凯医药（2105）的买入评级